Envoy Medical Announces Reverse Stock Split

White Bear Lake, Minnesota--(Newsfile Corp. - October 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it will implement a 1-for-10 reverse stock split of its outstanding shares of Class A common stock ("Common Stock"), effective at 12:01 a.m. Eastern Time on October 26, 2026 (the "Reverse Split"). The Company's Common Stock will continue to trade on the Nasdaq Capital Market ("Nasdaq") under the symbol "COCH" and will begin trading on a reverse split-adjusted basis at market open on October 26, 2026. Following the Reverse Split, the Common Stock will trade underthe new CUSIP number 29415V307.

The Reverse Split was authorized by the Company's stockholders at a Special Meeting held October 12, 2026. The Reverse Split is intended to maintain compliance with the $1.00 minimum bid price requirement for continued listing of the Company's Common Stock on Nasdaq and may improve trading liquidity by increasing the price per share of our Class A common stock, which could enable a broader range of institutions to invest.